A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma.
Ahmed Omar KasebS Cheenu KappadathSunyoung S LeeKanwal Pratap RaghavYehia I MohamedLianchun XiaoJeffrey S MorrisChimela OhajiRony AvritscherBruno C OdisioJoshua KubanMohamed E AbdelsalamBeth ChasenKhaled M ElsayesMohamed ElbananRobert A WolffJames C YaoArmeen MahvashPublished in: Journal of hepatocellular carcinoma (2021)
NCT01900002.